levofloxacin hydrate

Levofloxacin hydrate (Cravit hydrate) is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth.

Levofloxacin-D3 is a deuterated compound of Levofloxacin. Levofloxacin (T6567) has a CAS number of 100986-85-4. Levofloxacin (T6567) is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.

Levofloxacin-13C,D3 is a carbon-13 and deuterium-labeled version of Levofloxacin (TMSM-3455). It is a synthetic fluoroquinolone antibiotic that inhibits the DNA gyrase enzyme's supercoiling activity in bacteria, thereby preventing DNA replication.

Levofloxacin ((-)-Ofloxacin) is a synthetic fluoroquinolone antibiotic that inhibits the superhelical activity of bacterial DNA rotamase and prevents DNA replication. Levofloxacin is a broad-spectrum antibiotic used for the treatment of a wide range of bacterial infections.

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth.

Levofloxacin sodium is a synthetic fluoroquinolones antibacterial. It inhibits the supercoiling activity of bacterial DNA gyrase, so that halting DNA replication.

Levofloxacin-D3 (Standard) is a reference standard of Levofloxacin-D3 intended for quantitative analysis, quality control, and related biochemical research applications. Levofloxacin-d3 is a deuterated compound of Levofloxacin. Levofloxacin has a CAS number of 100986-85-4. Levofloxacin is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.

Levofloxacin mesylate is an orally active antibiotic effective against both Gram-positive and Gram-negative bacteria. It inhibits DNA gyrase and topoisomerase IV enzymes. Levofloxacin mesylate is employed in research related to chronic periodontitis, airway inflammation, and BK viremia. Additionally, it possesses anti-Orthopoxvirus activity.

Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.

Levofloxacin-13C,D3 (Standard) is a reference standard of Levofloxacin-13C,D3 intended for quantitative analysis, quality control, and related biochemical research applications. Levofloxacin-13C,d3 is a carbon-13 and deuterium-labeled version of Levofloxacin. It is a synthetic fluoroquinolone antibiotic that inhibits the DNA gyrase enzyme's supercoiling activity in bacteria, thereby preventing DNA replication.

Levofloxacin-D8 is a deuterated compound of Levofloxacin. Levofloxacin (T6567) has a CAS number of 100986-85-4. Levofloxacin (T6567) is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.

Levofloxacin (Standard) is a reference standard for research and analysis in studies involving Levofloxacin. Levofloxacin ((-)-Ofloxacin) is a synthetic fluoroquinolone antibiotic that inhibits the superhelical activity of bacterial DNA rotamase and prevents DNA replication. Levofloxacin is a broad-spectrum antibiotic used for the treatment of a wide range of bacterial infections.

Levofloxacin-D8 hydrochloride is the deuterated form of Levofloxacin hydrochloride (T8747).